Profile data is unavailable for this security.
About the company
Pro Medicus Limited is an Australia-based healthcare informatics company. The Company provides a full range of medical imaging software and services to hospitals, imaging centers and health care groups in Australia, North America and Europe. Its products include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro and Visage Ease. Its Visage RIS is a radiology information systems (RIS) medical software for practicing of management, training, installation and professional services. Visage RIS capabilities include patient registration, billing, scheduling, typing, HL7 integration, financial reporting, digital dictation and voice recognition integration. Its Visage 7.0 is a healthcare imaging software that provides clinicians with visualization capability for rapidly viewing 2-D, 3-D and 4-D medical images and picture archive and communication system (PACS)/digital imaging software that is sold directly and to original equipment manufacturers (OEM), training, installation and others.
- Revenue in AUD (TTM)166.33m
- Net income in AUD82.79m
- Incorporated1983
- Employees79.00
- LocationPro Medicus LtdRichmond, 450 Swan StRICHMOND 3121AustraliaAUS
- Phone+61 39429-8800
- Fax+61 39429-9455
- Websitehttps://www.promed.com.au/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sysmex Corp | 4.87bn | 530.08m | 19.30bn | 10.04k | 36.10 | 4.37 | 21.26 | 3.96 | 85.64 | 85.64 | 787.09 | 707.21 | 0.8356 | 2.80 | 3.67 | 48,923,520.00 | 9.11 | 8.92 | 11.11 | 11.29 | 53.49 | 52.27 | 10.90 | 11.19 | 2.42 | 9.63 | 0.1119 | 39.12 | 12.43 | 9.47 | 8.42 | 3.79 | 11.61 | 3.71 |
| Cochlear Ltd | 2.24bn | 356.80m | 19.35bn | 5.00k | 54.44 | 10.52 | 43.80 | 8.65 | 5.43 | 5.43 | 34.02 | 28.10 | 0.8414 | 1.54 | 4.82 | 447,120.00 | 13.43 | 8.55 | 17.39 | 11.15 | 75.84 | 75.05 | 15.96 | 11.98 | 1.68 | -- | 0.1169 | 91.14 | 15.47 | 9.40 | 18.70 | 5.22 | -4.76 | 4.44 |
| Fisher & Paykel Healthcare Corporatn Ltd | 1.58bn | 120.19m | 19.66bn | 7.14k | 163.28 | 12.27 | 87.84 | 12.44 | 0.2266 | 0.2266 | 2.97 | 3.01 | 0.777 | 2.04 | 7.33 | 244,055.50 | 5.91 | 16.43 | 6.96 | 19.83 | 59.93 | 62.09 | 7.61 | 19.07 | 0.9987 | 18.03 | 0.0971 | 49.48 | 10.23 | 10.24 | -47.02 | -8.72 | 20.52 | 12.29 |
| Pro Medicus Limited | 166.33m | 82.79m | 21.41bn | 79.00 | 259.01 | 113.95 | 234.47 | 128.70 | 0.7909 | 0.7909 | 1.59 | 1.80 | 0.7239 | 5.79 | 3.72 | -- | 36.03 | 32.19 | 42.01 | 37.84 | 99.82 | 99.58 | 49.78 | 47.15 | 5.98 | 104.83 | 0.0109 | 33.66 | 30.63 | 27.00 | 36.52 | 34.05 | -2.38 | 37.97 |
| Shanghai United Img Hlthcare Co Ltd | 2.34bn | 338.90m | 24.36bn | 7.44k | 71.65 | 5.91 | -- | 10.39 | 1.92 | 1.92 | 13.33 | 23.33 | 0.4349 | 1.14 | 3.17 | 1,469,437.00 | 6.25 | -- | 8.16 | -- | 48.41 | -- | 14.37 | -- | 2.27 | -- | 0.0263 | -- | 23.52 | -- | 19.21 | -- | -- | -- |
| Olympus Corp | 9.65bn | 869.93m | 29.33bn | 28.84k | 33.50 | 4.09 | 19.22 | 3.04 | 74.96 | 64.33 | 829.69 | 614.61 | 0.6525 | 1.69 | 5.76 | 33,760,840.00 | 5.88 | 6.38 | 8.19 | 9.06 | 67.75 | 65.88 | 9.01 | 9.91 | 1.12 | 39.59 | 0.2588 | 21.73 | 6.16 | 3.35 | -80.69 | 26.71 | 1.01 | 19.14 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 02 Oct 2024 | 1.80m | 1.73% |
| BlackRock Fund Advisorsas of 03 Oct 2024 | 1.11m | 1.06% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 902.60k | 0.86% |
| Vanguard Investments Australia Ltd.as of 30 Sep 2024 | 844.61k | 0.81% |
| Brown Capital Management LLCas of 30 Jun 2024 | 599.95k | 0.57% |
| Geode Capital Management LLCas of 07 Nov 2024 | 592.99k | 0.57% |
| DFA Australia Ltd.as of 30 Sep 2024 | 485.45k | 0.47% |
| Franklin Advisers, Inc.as of 03 Oct 2024 | 457.60k | 0.44% |
| BetaShares Capital Ltd.as of 31 Oct 2024 | 455.20k | 0.44% |
| Netwealth Investments Ltd.as of 30 Jun 2024 | 370.14k | 0.35% |
